NGM   $1.54  -0.64% Market Open

NGM Biopharmaceuticals Inc

EMA (20): 2024-04-01 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2024-01-02 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2024-01-23 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

Trend Type down and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -1.28%
EMA (20) date of signal April 1, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 26.23%
EMA (50) date of signal Jan. 2, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 19.38%
EMA (100) date of signal Jan. 23, 2024, 3 a.m.
RSI Signals bearish
RSI (14) Yield 0.0
RSI (14) date of signal April 4, 2024, 3 a.m.
MACD Signals bearish reversal
MACD Yield -1.28%
MACD date of signal April 1, 2024, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -1.28%
Stochastic date of signal April 3, 2024, 3 a.m.
Updated April 10, 2024, 11:03 p.m.